Tirzepatide Explores New Indications and Oral Formulation Development

Tirzepatide, currently an injectable for diabetes and weight management, is undergoing late-stage trials for an oral pill form, with potential regulatory approval by 2026. Research is also investigating its use for other conditions like heart failure, MASH, and sleep apnea, expanding its potential therapeutic applications. While the oral form offers convenience, its comparative efficacy and side effect profile are still under evaluation.